The Association of c-myc Rearrangements with Specific Types of Human Non-Hodgkin's Lymphomas

References

• Spencer C. A., Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 1990; 56: 1
   Web of Science ®Google Scholar
• Larsson L.-G., Schena M., Carlsson M., Sällström J., Nilsson K. Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells. Blood 1991; 77: 1025
   PubMed Web of Science ®Google Scholar
• Inghirami G., Grignani F., Sternas L., Lombardi L., Knowles D. M., Dalla-Favera R. Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. Science 1990; 250: 682
   PubMed Web of Science ®Google Scholar
• Bukh A., Martinez-Valdez H., Freedman S. J., Freedman M. H., Cohen A. The expression of c-fos, c-jun, and c-myc genes is regulated by heat shock in human lymphoid cells. J. Immunol. 1990; 144: 4835
   PubMed Web of Science ®Google Scholar
• Roberts P., Jones M., Gale R., Thomas S., Tidman N., Linch D. The c-myc oncogene is regulated independently of differentiation in myeloid cell lines. Leuk. Res. 1989; 13: 651
   PubMed Web of Science ®Google Scholar
• Blackwood E. M., Eisenman R. N. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991; 251: 1211
   PubMed Web of Science ®Google Scholar
• Ramsay G. M., Moscovici G., Moscovici C., Bishop J. M. Neoplastic transformation and tumorigenesis by the human protooncogene. MYC. Proc. Nail. Acad. Sci. USA 1990; 87: 2102
   PubMed Web of Science ®Google Scholar
• Cory S., Adams J. M. Transgenic mice and oncogenesis. Annu. Rev. Immunol. 1988; 6: 25
   PubMed Web of Science ®Google Scholar
• Zajac-Kaya M., Gelmann P., Levens D. A point mutation of the c-myc locus in Burkitt lymphoma abolishes binding of a nuclear protein. Science 1988; 240: 1776
   PubMed Web of Science ®Google Scholar
• Eick D., Pollack A., Kofler E., Lenoir G. M., Rickinson A. B., Bornkamm G. W. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells. Oncogene 1990; 5: 1397
   PubMed Web of Science ®Google Scholar
• Nishikura K., Murray J. M. The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells. Oncogene 1988; 2: 493
   PubMed Web of Science ®Google Scholar
• Breuer M., Slebos R., Verbeek S., Van Lohuizen M., Wientjens E., Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature 1989; 340: 61
   PubMed Web of Science ®Google Scholar
• Van Lohuizen M., Verbeek S., Krimpenfort P., Domen J., Saris C., Radaskiewicz T., Berns A. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 1989; 56: 673
   PubMed Web of Science ®Google Scholar
• Rustgi A. K., Dyson N., Bernards R. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 1991; 352: 541
   PubMed Web of Science ®Google Scholar
• Gauwerky C. E., Haluska F. G., Tsujimoto Y., Nowell P. C., Croce C. M. Evolution of B-cell malignancy: pre-B-cell leukemia resulting from myc activation in a B-cell neoplasm with a rearranged bc12 gene. Proc. Natl. Acad. Sci. USA 1988; 85: 8548
   PubMed Web of Science ®Google Scholar
• Gauwerky C. E., Hoxie J., Nowell P. C., Croce C. M. Pre-B-cell leukemia with a t(8;14) and a t(14;18) translocation is preceded by follicular lymphoma. Oncogene 1988; 2: 431
   PubMed Web of Science ®Google Scholar
• de Jong D., Voetdijk B. M. H., Beverstock G. C., van Ommen G. J. B., Willemze R., Kluin Ph. M. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N. Engl. J. Med. 1988; 318: 1373
   PubMed Web of Science ®Google Scholar
• Lacy J., Summers W. P., Summers W. C. Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus. EMBO J. 1989; 8: 1973
   PubMed Web of Science ®Google Scholar
• Haluska F. G., Russo G., Kant J., Andreef M., Croce C. M. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt lymphomas: Implications for their pathogenesis. Proc. Natl. Acad. Sci. USA 1989; 86: 8907
   PubMed Web of Science ®Google Scholar
• Felsher D. W., Rhim S.-H., Braun J. A murine model for B-cell lymphomagenesis in immunocompromised hosts: Natural killer cells are an important component of host resistance to premalignant B-cell lines. Cancer Res. 1990; 50: 7050
   PubMed Web of Science ®Google Scholar
• Felsher D. W., Denis K. A., Weiss D., Ando D. T., Braun J. A murine model for B-cell lymphomagenesis in immunocompromised hosts: c-myc-rearranged B-cell lines with a premalignant phenotype. Cancer Res. 1990; 50: 7042
   PubMed Web of Science ®Google Scholar
• Mallet M. K., Mane S. M., Meltzer S. J., Needleman S. W. C-Myc amplification coexistent with activating N-ras point mutation in the biphenotypic leukemic cell line RED-2. Leukemia 1989; 3: 511
   PubMed Web of Science ®Google Scholar
• Gauwerky C. E., Huebner K., Isobe M., Nowell P. C., Croce C. M. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc. Natl. Acad. Sci. USA 1989; 86: 8867
   PubMed Web of Science ®Google Scholar
• Van Krieken J. H. J. M., Raffeld M., Raghoebier S., Jaffe E. S., Van Ommen G. J.B., Kluin Ph. M. Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: Unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. Blood 1990; 76: 797
   PubMed Web of Science ®Google Scholar
• Scarpa A., Borgato L., Chilosi M., Capelli P., Menestrina F., Bonetti F., Zamboni G., Pizzolo G., Hirohashi S., Fiore-Donati L. Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphona of young adult age. Blood 1991; 78: 780
   PubMed Web of Science ®Google Scholar
• Haluska F. G., Finver S., Tsujimoto Y., Croce C. M. The t(8;14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Nature 1986; 324: 158
   PubMed Web of Science ®Google Scholar
• Haluska F. G., Tsujimoto Y., Croce C. M. The t(8;14) chromosome translocation of the Burkitt lymphoma cell line Daudi occurred during immunoglobulin gene rearrangement and involved the heavy chain diversity region. Proc. Natl. Acad. Sci. USA 1987; 84: 6835
   PubMed Web of Science ®Google Scholar
• Neri A., Barriga F., Knowles D. M., Magrath I. T., Favera R. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphomas. Proc. Natl. Acad. Sci. USA 1968; 85: 2748
   Web of Science ®Google Scholar
• Magrath I. Pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 1990; 55: 133
   PubMedGoogle Scholar
• Shiramizu B., Barriga F., Neequaye J., Jafri A., Dalla-Favera R., Neri A., Guttierez M., Levine P., Magrath I. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: Relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516
   PubMed Web of Science ®Google Scholar
• Yano T., Van Krieken J. H. J. M., Magrath I. T., Jaffe D. L., Raffeld M. Histogenetic correlations between subcategories of small non-cleaved cell lymphomas. Am. J. Pathol, in press. 1992
   Google Scholar
• Ladanyi M., Offit K., Jhanwar S. C., Filippa D. A., Chaganti R. S. K. MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood 1991; 77: 1057
   PubMed Web of Science ®Google Scholar
• Donti E., Falini B., Pelicci P. G., Donti G. V., Rosetti A., Martelli M., Grignani F. Immunological and molecular studies in a case of follicular lymphoma with an extra chromosome 12 and t(2;8) translocation. Leukemia 1988; 2: 41
   PubMed Web of Science ®Google Scholar
• Park J. K., McKeithan T. W., Le Beau M. M., Bitter M. A., Franklin W. A., Rowley J. D., Diaz M. O. An (8;14)(q24;q11) translocation involving the T-cell receptor alpha-chain gene and the myc oncogene 3′ region in a B-cell lymphoma. Gen. Chrom. Cane. 1989; 1: 15
   PubMed Web of Science ®Google Scholar
• Raghoebier S., Kramer M. H. H., Van Krieken J. H. J. M., Jong D., Limpens J., Kluin-Nelemans J. C., Van Ommen G. J. B., Kluin Ph. M. Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma. Blood 1991; 78: 2680
   PubMed Web of Science ®Google Scholar
• Palumbo A. P., Boccadoro M., Battaglio S., Corradini P., Tsichlis P. N., Huebner K., Piled A., Croce C. M. Human homologue of Moloney leukemia virus integration-4 locus (MLVI-4), located 20 kilobases 3 of the myc gene, is rearranged in multiple myelomas. Cancer Res. 1990; 50: 6478
   PubMed Web of Science ®Google Scholar
• Selvanayagam P., Blick M., Narni F., Van Tuinen P., Ledbetter D. H., Alexanian R., Aunders G. F., Barlogie B. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood 1988; 71: 30
   PubMed Web of Science ®Google Scholar
• Subar M., Neri A., Inghirami G., Knowles D. M., Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988; 11: 667
   Google Scholar
• Pelicci P. G., Knowles D. M., Arlin Z. A., Wieczorek R., Luci W., Dina D., Basilico C., Dalla-Favera R. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. J. Exp. Med. 1986; 164: 2049
   PubMed Web of Science ®Google Scholar